{
    "cid": "LEGIARTI000026808100",
    "num": "L5138-3-1",
    "listArticle": [
        {
            "context": {
                "titresTM": [
                    {
                        "debut": "2000-06-22",
                        "fin": "2999-01-01",
                        "titre": "Partie l\u00e9gislative",
                        "xPath": "/ARTICLE/CONTEXTE/TEXTE/TM/TITRE_TM",
                        "cid": "LEGISCTA000006103419",
                        "id": "LEGISCTA000006103419",
                        "etat": "VIGUEUR"
                    },
                    {
                        "debut": "2000-06-22",
                        "fin": "2999-01-01",
                        "titre": "Cinqui\u00e8me partie : Produits de sant\u00e9",
                        "xPath": "/ARTICLE/CONTEXTE/TEXTE/TM/TM/TITRE_TM",
                        "cid": "LEGISCTA000006125349",
                        "id": "LEGISCTA000006125349",
                        "etat": "VIGUEUR"
                    },
                    {
                        "debut": "2000-06-22",
                        "fin": "2999-01-01",
                        "titre": "Livre Ier : Produits pharmaceutiques",
                        "xPath": "/ARTICLE/CONTEXTE/TEXTE/TM/TM/TM/TITRE_TM",
                        "cid": "LEGISCTA000006140630",
                        "id": "LEGISCTA000006140630",
                        "etat": "VIGUEUR"
                    },
                    {
                        "debut": "2000-06-22",
                        "fin": "2999-01-01",
                        "titre": "Titre III : Autres produits et substances pharmaceutiques r\u00e9glement\u00e9s",
                        "xPath": "/ARTICLE/CONTEXTE/TEXTE/TM/TM/TM/TM/TITRE_TM",
                        "cid": "LEGISCTA000006155086",
                        "id": "LEGISCTA000006155086",
                        "etat": "VIGUEUR"
                    },
                    {
                        "debut": "2000-06-22",
                        "fin": "2999-01-01",
                        "titre": "Chapitre VIII : Mati\u00e8res premi\u00e8res \u00e0 usage pharmaceutique.",
                        "xPath": "/ARTICLE/CONTEXTE/TEXTE/TM/TM/TM/TM/TM/TITRE_TM",
                        "cid": "LEGISCTA000006171382",
                        "id": "LEGISCTA000006171382",
                        "etat": "VIGUEUR"
                    }
                ],
                "nombreVersionParent": 1,
                "longeurChemin": 47,
                "titreTxt": [
                    {
                        "debut": "1953-10-07",
                        "fin": "2999-01-01",
                        "titre": "Code de la sant\u00e9 publique",
                        "xPath": "/ARTICLE/CONTEXTE/TEXTE/TITRE_TXT",
                        "cid": "LEGITEXT000006072665",
                        "id": "LEGITEXT000006072665",
                        "etat": "VIGUEUR"
                    }
                ]
            },
            "etat": "VIGUEUR",
            "id": "LEGIARTI000045404930",
            "lienAutres": [],
            "lienCitations": [
                {
                    "textCid": "LEGITEXT000006072665",
                    "textTitle": "Code de la sant\u00e9 publique - art. L5138-3 (V)",
                    "linkType": "CITATION",
                    "linkOrientation": "source",
                    "articleNum": "L5138-3",
                    "articleId": "LEGIARTI000045404937",
                    "natureText": "CODE",
                    "date": 1648156247084,
                    "parentCid": null,
                    "numTexte": "",
                    "datePubli": 32472144000000,
                    "dateDebut": 1648166400000
                },
                {
                    "textCid": "LEGITEXT000006072665",
                    "textTitle": "Code de la sant\u00e9 publique - art. L5142-1",
                    "linkType": "CITATION",
                    "linkOrientation": "source",
                    "articleNum": "L5142-1",
                    "articleId": "LEGIARTI000006690231",
                    "natureText": "CODE",
                    "date": 1648156247084,
                    "parentCid": null,
                    "numTexte": "",
                    "datePubli": 32472144000000,
                    "dateDebut": 1648166400000
                }
            ],
            "lienConcordes": [],
            "lienModifications": [
                {
                    "textCid": "JORFTEXT000045398547",
                    "textTitle": "Ordonnance n\u00b02022-414 du 23 mars 2022 - art. 2",
                    "linkType": "MODIFIE",
                    "linkOrientation": "cible",
                    "articleNum": "2",
                    "articleId": "LEGIARTI000045398873",
                    "natureText": "ORDONNANCE",
                    "datePubliTexte": "2022-03-24",
                    "dateSignaTexte": "2022-03-23",
                    "dateDebutCible": "2022-03-25"
                }
            ],
            "num": "L5138-3-1",
            "origine": "LEGI",
            "texte": "Pour la fabrication de m\u00e9dicaments \u00e0 usage v\u00e9t\u00e9rinaire, les \u00e9tablissements pharmaceutiques mentionn\u00e9s \u00e0 l'article L. 5142-1 , les v\u00e9t\u00e9rinaires, les pharmacies d'officine et les personnes autoris\u00e9es \u00e0 pr\u00e9parer des autovaccins \u00e0 usage v\u00e9t\u00e9rinaire ainsi que les personnes autoris\u00e9es \u00e0 pr\u00e9parer les m\u00e9dicaments v\u00e9t\u00e9rinaires mentionn\u00e9es \u00e0 l'article L. 5142-1-2 utilisent, en tant que mati\u00e8res premi\u00e8res \u00e0 usage pharmaceutique, des substances actives r\u00e9pondant aux exigences du deuxi\u00e8me alin\u00e9a de l'article L. 5138-3 .",
            "texteHtml": "<p>Pour la fabrication de m\u00e9dicaments \u00e0 usage v\u00e9t\u00e9rinaire, les \u00e9tablissements pharmaceutiques mentionn\u00e9s \u00e0 l'article <a href='/article/LEGIARTI000006690231'>L. 5142-1</a>, les v\u00e9t\u00e9rinaires, les pharmacies d'officine et les personnes autoris\u00e9es \u00e0 pr\u00e9parer des autovaccins \u00e0 usage v\u00e9t\u00e9rinaire ainsi que les personnes autoris\u00e9es \u00e0 pr\u00e9parer les m\u00e9dicaments v\u00e9t\u00e9rinaires mentionn\u00e9es \u00e0 l'article L. 5142-1-2 utilisent, en tant que mati\u00e8res premi\u00e8res \u00e0 usage pharmaceutique, des substances actives r\u00e9pondant aux exigences du deuxi\u00e8me alin\u00e9a de l'article <a href='/article/LEGIARTI000045404937' title='Code de la sant\u00e9 publique - art. L5138-3 (V)'>L. 5138-3</a>.</p>",
            "type": "AUTONOME",
            "dateDebut": "2022-03-25T00:00:00.000Z",
            "dateFin": "2999-01-01T00:00:00.000Z"
        },
        {
            "context": {
                "titresTM": [
                    {
                        "debut": "2000-06-22",
                        "fin": "2999-01-01",
                        "titre": "Partie l\u00e9gislative",
                        "xPath": "/ARTICLE/CONTEXTE/TEXTE/TM/TITRE_TM",
                        "cid": "LEGISCTA000006103419",
                        "id": "LEGISCTA000006103419",
                        "etat": "VIGUEUR"
                    },
                    {
                        "debut": "2000-06-22",
                        "fin": "2999-01-01",
                        "titre": "Cinqui\u00e8me partie : Produits de sant\u00e9",
                        "xPath": "/ARTICLE/CONTEXTE/TEXTE/TM/TM/TITRE_TM",
                        "cid": "LEGISCTA000006125349",
                        "id": "LEGISCTA000006125349",
                        "etat": "VIGUEUR"
                    },
                    {
                        "debut": "2000-06-22",
                        "fin": "2999-01-01",
                        "titre": "Livre Ier : Produits pharmaceutiques",
                        "xPath": "/ARTICLE/CONTEXTE/TEXTE/TM/TM/TM/TITRE_TM",
                        "cid": "LEGISCTA000006140630",
                        "id": "LEGISCTA000006140630",
                        "etat": "VIGUEUR"
                    },
                    {
                        "debut": "2000-06-22",
                        "fin": "2999-01-01",
                        "titre": "Titre III : Autres produits et substances pharmaceutiques r\u00e9glement\u00e9s",
                        "xPath": "/ARTICLE/CONTEXTE/TEXTE/TM/TM/TM/TM/TITRE_TM",
                        "cid": "LEGISCTA000006155086",
                        "id": "LEGISCTA000006155086",
                        "etat": "VIGUEUR"
                    },
                    {
                        "debut": "2000-06-22",
                        "fin": "2999-01-01",
                        "titre": "Chapitre VIII : Mati\u00e8res premi\u00e8res \u00e0 usage pharmaceutique.",
                        "xPath": "/ARTICLE/CONTEXTE/TEXTE/TM/TM/TM/TM/TM/TITRE_TM",
                        "cid": "LEGISCTA000006171382",
                        "id": "LEGISCTA000006171382",
                        "etat": "VIGUEUR"
                    }
                ],
                "nombreVersionParent": 1,
                "longeurChemin": 47,
                "titreTxt": [
                    {
                        "debut": "1953-10-07",
                        "fin": "2999-01-01",
                        "titre": "Code de la sant\u00e9 publique",
                        "xPath": "/ARTICLE/CONTEXTE/TEXTE/TITRE_TXT",
                        "cid": "LEGITEXT000006072665",
                        "id": "LEGITEXT000006072665",
                        "etat": "VIGUEUR"
                    }
                ]
            },
            "etat": "MODIFIE",
            "id": "LEGIARTI000026808100",
            "lienAutres": [],
            "lienCitations": [
                {
                    "textCid": "LEGITEXT000006072665",
                    "textTitle": "Code de la sant\u00e9 publique - art. L5138-3",
                    "linkType": "CITATION",
                    "linkOrientation": "source",
                    "articleNum": "L5138-3",
                    "articleId": "LEGIARTI000006690170",
                    "natureText": "CODE",
                    "date": 1648156250498,
                    "parentCid": null,
                    "numTexte": "",
                    "datePubli": 32472144000000,
                    "dateDebut": 961632000000
                },
                {
                    "textCid": "LEGITEXT000006072665",
                    "textTitle": "Code de la sant\u00e9 publique - art. L5142-1",
                    "linkType": "CITATION",
                    "linkOrientation": "source",
                    "articleNum": "L5142-1",
                    "articleId": "LEGIARTI000006690231",
                    "natureText": "CODE",
                    "date": 1648156250498,
                    "parentCid": null,
                    "numTexte": "",
                    "datePubli": 32472144000000,
                    "dateDebut": 1648166400000
                }
            ],
            "lienConcordes": [],
            "lienModifications": [
                {
                    "textCid": "JORFTEXT000026805101",
                    "textTitle": "Ordonnance n\u00b02012-1427\n du 19 d\u00e9cembre 2012 - art. 10",
                    "linkType": "CREE",
                    "linkOrientation": "cible",
                    "articleNum": "10",
                    "articleId": "LEGIARTI000026806476",
                    "natureText": "ORDONNANCE",
                    "datePubliTexte": "2012-12-21",
                    "dateSignaTexte": "2012-12-19",
                    "dateDebutCible": "2012-12-22"
                }
            ],
            "num": "L5138-3-1",
            "origine": "LEGI",
            "texte": "Pour la fabrication de m\u00e9dicaments \u00e0 usage v\u00e9t\u00e9rinaire, les \u00e9tablissements pharmaceutiques mentionn\u00e9s \u00e0 l'article L. 5142-1 , les v\u00e9t\u00e9rinaires, les pharmacies d'officine et les personnes autoris\u00e9es \u00e0 pr\u00e9parer des autovaccins \u00e0 usage v\u00e9t\u00e9rinaire utilisent, en tant que mati\u00e8res premi\u00e8res \u00e0 usage pharmaceutique, des substances actives r\u00e9pondant aux exigences du premier alin\u00e9a de l'article L. 5138-3 .",
            "texteHtml": "Pour la fabrication de m\u00e9dicaments \u00e0 usage v\u00e9t\u00e9rinaire, les \u00e9tablissements pharmaceutiques mentionn\u00e9s \u00e0 l'article <a href='/article/LEGIARTI000006690231'>L. 5142-1</a>, les v\u00e9t\u00e9rinaires, les pharmacies d'officine et les personnes autoris\u00e9es \u00e0 pr\u00e9parer des autovaccins \u00e0 usage v\u00e9t\u00e9rinaire utilisent, en tant que mati\u00e8res premi\u00e8res \u00e0 usage pharmaceutique, des substances actives r\u00e9pondant aux exigences du premier alin\u00e9a de l'article <a href='/article/LEGIARTI000006690170'>L. 5138-3</a>.",
            "type": "AUTONOME",
            "dateDebut": "2012-12-22T00:00:00.000Z",
            "dateFin": "2022-03-25T00:00:00.000Z"
        }
    ]
}